Shao‐Lee Lin
- Immunology top 2%
- IL-33, ST2, and ILC Pathways 2
- Physiology top 2%
- Asthma and respiratory diseases 11
- Immunology and Allergy top 2%
- Allergic Rhinitis and Sensitization 2
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 3
- Dermatology top 2%
- Dermatology and Skin Diseases 2
-
- Respiratory and Cough-Related Research 4
-
- Global Health Care Issues 2
-
- Inflammatory Bowel Disease 2
- Co-authors
- Yun ChonWilliam W. BusseJingYuan FengStephen T. HolgateEdward KerwinJoseph LinDenise GlobeVahram Ghushchyan
- Journals
- Journal of Allergy and Clinical Immunology (5 papers)Journal of Asthma (3 papers)The Journal of Rheumatology (2 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Shao‐Lee Lin
20 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 1.0k
- Physiology 1.1k
- Immunology and Allergy 219
- Hematology 330
- Dermatology 243
Countries citing papers authored by Shao‐Lee Lin
This map shows the geographic impact of Shao‐Lee Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Lee Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Lee Lin more than expected).
Fields of papers citing papers by Shao‐Lee Lin
This network shows the impact of papers produced by Shao‐Lee Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Lee Lin. The network helps show where Shao‐Lee Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shao‐Lee Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Diseasebreakdown → | 2016 | 289 |
| 2 | 2015 | 65 | |
| 3 | 2014 | 256 | |
| 4 | 2014 | 67 | |
| 5 | 2014 | 51 | |
| 6 | 2013 | 49 | |
| 7 | Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthmabreakdown → | 2013 | 506 |
| 8 | 2013 | 15 | |
| 9 | 2013 | 10 | |
| 10 | 2012 | 35 | |
| 11 | 2012 | 73 | |
| 12 | 2011 | 42 | |
| 13 | 2011 | 142 | |
| 14 | 2010 | 228 | |
| 15 | 2010 | 91 | |
| 16 | 2010 | 21 | |
| 17 | 2009 | 38 | |
| 18 | 2009 | 3 | |
| 19 | 2008 | 219 | |
| 20 | 2005 | 178 |
About Shao‐Lee Lin
Shao‐Lee Lin is a scholar working on Physiology, Immunology and Allergy, Hematology, Dermatology and Immunology, having authored 21 papers that have together received 2.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (11 papers), Respiratory and Cough-Related Research (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Global Health Care Issues (2 papers), Dermatology and Skin Diseases (2 papers), Allergic Rhinitis and Sensitization (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Immunology (1.0k citations), Physiology (1.1k citations), Immunology and Allergy (219 citations), Hematology (330 citations) and Dermatology (243 citations). Shao‐Lee Lin has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Yun Chon, William W. Busse, JingYuan Feng, Stephen T. Holgate, Edward Kerwin, Joseph Lin, Denise Globe, Vahram Ghushchyan, Patrick W. Sullivan and Richard Newmark. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Journal of Asthma, The Journal of Rheumatology, American Journal of Respiratory and Critical Care Medicine and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.